Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1038 | 1046 | 1087 | 1100 | 1329 | - |
Fund Return | 3.85% | 4.58% | 8.69% | 3.23% | 5.86% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CIFM China Emerging Power Class A | 4.81B | 4.38 | -9.49 | 12.16 | ||
CIFM China Emerging Power Class H | 4.81B | 4.41 | -9.52 | - | ||
CIFM Technology Qian Yan Alloc | 2.66B | 1.69 | -12.59 | - | ||
China Intl AsiaPacific Advantage St | 2.49B | 2.18 | -6.57 | 4.85 | ||
China International China Advanced | 2.27B | 4.85 | -9.42 | 10.05 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF Global Selction Eq QDII | 8.18B | 10.93 | 0.73 | 12.70 | ||
ChinaAMC Global Selective Fund QDII | 2.09B | 10.58 | -6.75 | 2.20 | ||
China Southern Intl Select Alloc | 1.57B | 6.11 | -8.42 | 3.20 | ||
ICBC Credit Suisse China Opportunit | 542.21M | 9.08 | -3.10 | 9.58 | ||
ICBC Credit Suisse Global Selected | 414.59M | 9.24 | 4.96 | 11.29 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 3.36 | 34.41 | +1.31% | |
Novo Nordisk B | DK0062498333 | 2.98 | 883.2 | +0.07% | |
Novartis | CH0012005267 | 2.74 | 92.32 | +1.97% | |
TotalEnergies SE | FR0000120271 | 2.54 | 68.68 | +0.48% | |
Air Liquide | FR0000120073 | 2.23 | 186.64 | -0.17% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review